Total Payments
$24,286
2024 Payments
$1,556
Companies
28
Transactions
318
Medicare Patients
9,238
Medicare Billing
$4.9M
Payment Breakdown by Category
Food & Beverage$12,132 (50.0%)
Other$9,190 (37.8%)
Consulting$2,500 (10.3%)
Travel$351.12 (1.4%)
Education$93.64 (0.4%)
Gifts$19.40 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,132 | 300 | 50.0% |
| Acquisitions | $5,543 | 1 | 22.8% |
| Current or prospective ownership or investment interest | $3,647 | 5 | 15.0% |
| Consulting Fee | $2,500 | 1 | 10.3% |
| Travel and Lodging | $351.12 | 3 | 1.4% |
| Education | $93.64 | 1 | 0.4% |
| Gift | $19.40 | 1 | 0.1% |
| Unspecified | $0 | 6 | 0.0% |
Payments by Type
General
$24,286
312 transactions
Ownership
$0
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| US Retina LLC | $9,190 | 12 | $0 (2022) |
| Allergan, Inc. | $4,026 | 37 | $0 (2021) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $1,440 | 33 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $1,429 | 53 | $0 (2024) |
| Genentech USA, Inc. | $1,151 | 51 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $1,145 | 16 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $657.82 | 15 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $598.41 | 10 | $0 (2023) |
| Alimera Sciences, Inc. | $587.22 | 16 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $574.02 | 9 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,556 | 38 | ABBVIE INC. ($331.69) |
| 2023 | $2,563 | 46 | Ortho Dermatologics, a division of Bausch Health US, LLC ($440.34) |
| 2022 | $8,146 | 43 | US Retina LLC ($7,095) |
| 2021 | $2,226 | 33 | US Retina LLC ($976.15) |
| 2020 | $998.24 | 21 | US Retina LLC ($483.92) |
| 2019 | $2,647 | 51 | US Retina LLC ($634.83) |
| 2018 | $1,304 | 39 | Allergan Inc. ($321.24) |
| 2017 | $4,845 | 47 | Allergan Inc. ($3,315) |
All Payment Transactions
318 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $8.08 | General |
| Category: Ophthalmology | ||||||
| 11/20/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $31.28 | General |
| Category: Ophthalmology | ||||||
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $9.96 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: EYE CARE | ||||||
| 11/13/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/06/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/30/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/21/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/02/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $33.10 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/25/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $142.17 | General |
| Category: Ophthalmology | ||||||
| 09/24/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $31.10 | General |
| Category: Ophthalmology | ||||||
| 09/17/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $30.98 | General |
| Category: Ophthalmology | ||||||
| 09/11/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 09/10/2024 | Alimera Sciences, Inc. | ILUVIEN (Drug), YUTIQ | Food and Beverage | In-kind items and services | $96.00 | General |
| Category: treatment of diabetic macular edema in patients who have been previously treated with corticosteroid | ||||||
| 08/28/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/28/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: EYE CARE | ||||||
| 08/14/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: Ophthalmology | ||||||
| 08/12/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/07/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $27.92 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/05/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $31.11 | General |
| Category: Ophthalmology | ||||||
| 07/23/2024 | Apellis Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $106.80 | General |
| 07/10/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/12/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $33.31 | General |
| Category: Ophthalmology | ||||||
| 06/04/2024 | Alimera Sciences, Inc. | ILUVIEN (Drug), YUTIQ | Food and Beverage | In-kind items and services | $96.00 | General |
| Category: treatment of diabetic macular edema in patients who have been previously treated with corticosteroid | ||||||
| 06/04/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 2,199 | 11,937 | $1.8M | $1.1M |
| 2022 | 12 | 2,255 | 6,235 | $1.9M | $1.3M |
| 2021 | 13 | 2,313 | 6,302 | $1.9M | $1.2M |
| 2020 | 13 | 2,471 | 6,632 | $2.2M | $1.3M |
Total Patients
9,238
Total Services
31,106
Medicare Billing
$4.9M
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 127 | 1,038 | $1.0M | $714,930 | 70.3% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 32 | 6,540 | $247,866 | $190,130 | 76.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 525 | 1,076 | $170,008 | $95,148 | 56.0% |
| 67028 | Injection of drug into eye | Office | 2023 | 162 | 630 | $126,000 | $55,936 | 44.4% |
| 92134 | Imaging of retina | Office | 2023 | 568 | 1,333 | $99,975 | $39,072 | 39.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 127 | 127 | $22,860 | $15,645 | 68.4% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 459 | 956 | $23,900 | $10,584 | 44.3% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 11 | 11 | $51,535 | $9,831 | 19.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 107 | $10,700 | $6,919 | 64.7% |
| 92250 | Photography of the retina | Office | 2023 | 57 | 57 | $4,560 | $1,621 | 35.5% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 12 | 12 | $2,100 | $1,257 | 59.9% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 14 | 18 | $3,690 | $684.18 | 18.5% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 32 | 32 | $800.00 | $536.86 | 67.1% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 159 | 1,324 | $1.3M | $945,882 | 72.9% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 546 | 1,274 | $201,292 | $114,244 | 56.8% |
| 67028 | Injection of drug into eye | Office | 2022 | 175 | 710 | $142,000 | $64,177 | 45.2% |
| J3590 | Unclassified biologics | Office | 2022 | 19 | 49 | $69,237 | $51,650 | 74.6% |
| 92134 | Imaging of retina | Office | 2022 | 578 | 1,415 | $106,125 | $41,888 | 39.5% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2022 | 472 | 1,140 | $28,500 | $12,968 | 45.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 105 | 105 | $18,900 | $12,283 | 65.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 34 | $3,395 | $2,309 | 68.0% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 19 | 19 | $3,325 | $1,881 | 56.6% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2022 | 102 | 107 | $2,675 | $1,873 | 70.0% |
| 92250 | Photography of the retina | Office | 2022 | 45 | 46 | $3,680 | $1,311 | 35.6% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2022 | 11 | 12 | $2,460 | $463.26 | 18.8% |
About Dr. David Glaser, MD
Dr. David Glaser, MD is a Retina Specialist healthcare provider based in Florissant, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891807137.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Glaser, MD has received a total of $24,286 in payments from pharmaceutical and medical device companies, with $1,556 received in 2024. These payments were reported across 318 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($12,132).
As a Medicare-enrolled provider, Glaser has provided services to 9,238 Medicare beneficiaries, totaling 31,106 services with total Medicare billing of $4.9M. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Retina Specialist
- Location Florissant, MO
- Active Since 08/31/2006
- Last Updated 09/28/2022
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1891807137
Products in Payments
- OZURDEX (Drug) $3,950
- EYLEA (Biological) $741.63
- Lucentis (Biological) $600.10
- Vabysmo (Drug) $537.71
- ILUVIEN (Drug) $463.66
- EYLEA AFLIBERCEPT INJECTION (Biological) $413.41
- ENVISTA (Device) $375.00
- ACTHAR (Biological) $363.96
- enVista MX60 IOL (Device) $356.48
- STELLARIS (Device) $339.91
- ALTRENO (Drug) $327.75
- Syfovre (Drug) $325.42
- STELLARIS PC (Device) $314.46
- ARAZLO (Drug) $314.36
- Izervay (Drug) $308.65
- EYLEA HD (Biological) $273.48
- BEOVU (Drug) $265.22
- XIIDRA (Drug) $241.56
- YUTIQ (Drug) $233.90
- Prokera (Device) $209.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.